Article

Exploring Natural Compound Libraries for Breast Cancer Targets: An In Silico Study

2025-04-04

Abstract excerpt

Background: Breast cancer is a globally prevalent, heterogenous disease affecting both women and men across all ethnic groups. It is a complex disease and is the second most frequently diagnosed solid tumour in women worldwide. The PI3K/AKT/mTOR signalling pathway plays a significant role in breast cancer progression, survival, and drug resistance. It is dysregulated in approximately 20-34% of cases, making it a k...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d6069152-f5d1-59cf-8112-da35881713a8
DOI: 10.18311/jnr/2025/45930

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring Natural Compound Libraries for Breast Cancer Targets: An In Silico StudyDOI 10.18311/jnr/2025/45930Read

Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study.Semantic proximity Read

Molecular Docking Appraisal of Dysphania ambrosioides Phytochemicals as Potential Inhibitor of a Key Triple-negative Breast Cancer Driver GeneSemantic proximity Read

Validating linalool as a potential drug for breast cancer treatment based on machine learning and molecular dockingSemantic proximity Read

Oridonin inhibits aberrant AKT activation in breast cancerSemantic proximity Read

Network Pharmacology and Experimental Validation to Explore the Potential Mechanism of Nigella sativa for the Treatment of Breast CancerSemantic proximity Read

Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patientsSemantic proximity Read

Syringin Exerts Anti-Breast Cancer Effects Through PI3K-AKT and EGFR-RAS-RAF PathwaysSemantic proximity Read

Probing the mechanism of action (MOA) of Solanum nigrum Linn against breast cancer using network pharmacology and molecular dockingSemantic proximity Read

Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approachSemantic proximity Read

Genistein Mediated Molecular Pharmacology, Cell-Specific Anti-Breast Cancer Mechanism with Synergistic Effect and in silico Safety MeasurementSemantic proximity Read

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trialsSemantic proximity Read

Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancerSemantic proximity Read